Vera Therapeutics Ownership | Who Owns Vera Therapeutics?


OverviewForecastFinancialsChart

Vera Therapeutics Ownership Summary


Vera Therapeutics is owned by 97.41% institutional investors, 6.74% insiders. Avoro capital advisors is the largest institutional shareholder, holding 8.45% of VERA shares. T. Rowe Price New Horizons is the top mutual fund, with 2.48% of its assets in Vera Therapeutics shares.

VERA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVera Therapeutics97.41%6.74%-4.15%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avoro capital advisors4.31M8.45%$155.92M
Blackrock funding, inc. /de3.94M7.18%$166.69M
Price t rowe associates inc /md/3.62M7.10%$130.98M
Blackrock3.34M6.55%$120.76M
Fmr2.80M5.50%$101.37M
Sofinnova investments2.79M5.48%$101.09M
Vanguard group2.52M4.95%$91.32M
Commodore capital lp2.48M4.86%$89.55M
State street2.16M4.23%$77.99M
Eversept partners, lp2.04M4.01%$73.92M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Altium capital management lp714.00K10.54%$25.83M
Commodore capital lp2.48M6.11%$89.55M
Sofinnova investments2.79M5.25%$101.09M
Eversept partners, lp2.04M5.06%$73.92M
Portman32.80K4.48%$1.19M
Kynam capital management, lp1.54M4.31%$55.85M
First light asset management1.01M3.19%$36.39M
Logos global management lp950.00K2.76%$34.37M
Cutter capital management, lp230.00K2.51%$8.32M
Avoro capital advisors4.31M2.08%$155.92M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/3.62M0.02%1.23M
Holocene advisors, lp1.80M0.27%588.70K
Samlyn capital1.23M0.74%586.41K
First light asset management1.01M3.19%569.59K
Blackrock funding, inc. /de3.94M0.00%489.28K

Top Sellers

HolderShares% AssetsChange
Morgan stanley305.44K0.00%-1.23M
Point72 asset management119.00K0.01%-1.06M
Avoro capital advisors4.31M2.08%-955.41K
Commodore capital lp2.48M6.11%-690.00K
Polar capital---675.00K

New Positions

HolderShares% AssetsChangeValue
American century companies387.38K0.01%387.38K$14.02M
Federated hermes290.00K0.02%290.00K$10.49M
Schonfeld strategic advisors288.44K0.07%288.44K$10.44M
Cutter capital management, lp230.00K2.51%230.00K$8.32M
Gw&k investment management186.60K0.07%186.60K$7.89M

Sold Out

HolderChange
Pnc financial services group-5.00
Nelson, van denburg & campbell wealth management group-7.00
Capital performance advisors llp-11.00
Innealta capital-42.00
Comerica bank-48.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241781.71%53,475,7240.91%970.90%96-6.80%50-10.71%
Jun 30, 20241752.94%52,992,2973.28%1031.03%103-17.60%5686.67%
Mar 31, 202417075.26%51,310,37124.10%1001.07%125131.48%3042.86%
Dec 31, 20239712.79%41,345,6555.32%961.24%54-2131.25%
Sep 30, 2023862.38%39,258,8892.97%881.19%543.85%16-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price New Horizons1.57M2.48%-
US Small-Cap Growth II Equity Comp1.57M2.48%98.47K
Vanguard Total Stock Mkt Idx Inv1.48M2.33%14.11K
Fidelity Growth Compy Commingled Pl O1.16M2.11%-
iShares Russell 2000 ETF1.21M1.92%-9.20K
Fidelity Growth Compy Commingled Pl S1.19M1.87%12.41K
T. Rowe Price Integrated US SmCapGrEq989.96K1.56%534.29K
SPDR® S&P Biotech ETF945.72K1.49%-9.20K
Fidelity Growth Company Fund883.85K1.40%-18.04K
Vanguard Institutional Extnd Mkt Idx Tr839.83K1.33%35.58K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 08, 2025Fordyce Marshall PRESIDENT AND CEOSell$414.30K
Jan 08, 2025Fordyce Marshall PRESIDENT AND CEOSell$78.75K
Jan 08, 2025Fordyce Marshall PRESIDENT AND CEOSell$237.49K
Dec 18, 2024Fordyce Marshall PRESIDENT AND CEOSell$92.95K
Dec 18, 2024Fordyce Marshall PRESIDENT AND CEOSell$204.09K

Insider Transactions Trends


DateBuySell
2025 Q1-3
2024 Q4-31
2024 Q3-21
2024 Q2-24
2024 Q117

VERA Ownership FAQ


Who Owns Vera Therapeutics?

Vera Therapeutics shareholders are primarily institutional investors at 97.41%, followed by 6.74% insiders and -4.15% retail investors. The average institutional ownership in Vera Therapeutics's industry, Biotech Stocks , is 109.70%, which Vera Therapeutics falls below.

Who owns the most shares of Vera Therapeutics?

Vera Therapeutics’s largest shareholders are Avoro capital advisors (4.31M shares, 8.45%), Blackrock funding, inc. /de (3.94M shares, 7.18%), and Price t rowe associates inc /md/ (3.62M shares, 7.10%). Together, they hold 22.74% of Vera Therapeutics’s total shares outstanding.

Does Blackrock own Vera Therapeutics?

Yes, BlackRock owns 6.55% of Vera Therapeutics, totaling 3.34M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 120.76M$. In the last quarter, BlackRock increased its holdings by 18.71K shares, a 0.56% change.

Who is Vera Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Vera Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.54% of its assets in 714K Vera Therapeutics shares, valued at 25.83M$.

Who is the top mutual fund holder of Vera Therapeutics shares?

T. Rowe Price New Horizons is the top mutual fund holder of Vera Therapeutics shares, with 2.48% of its total shares outstanding invested in 1.57M Vera Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools